310 related articles for article (PubMed ID: 28690220)
41. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension.
Tunariu N; Gibbs SJ; Win Z; Gin-Sing W; Graham A; Gishen P; Al-Nahhas A
J Nucl Med; 2007 May; 48(5):680-4. PubMed ID: 17475953
[TBL] [Abstract][Full Text] [Related]
42. Pulmonary arterial hypertension in patients with sarcoidosis: the Pulsar single center experience.
Pabst S; Hammerstingl C; Grau N; Kreuz J; Grohe C; Juergens UR; Nickenig G; Skowasch D
Adv Exp Med Biol; 2013; 755():299-305. PubMed ID: 22826080
[TBL] [Abstract][Full Text] [Related]
43. Pressure-Flow During Exercise Catheterization Predicts Survival in Pulmonary Hypertension.
Hasler ED; Müller-Mottet S; Furian M; Saxer S; Huber LC; Maggiorini M; Speich R; Bloch KE; Ulrich S
Chest; 2016 Jul; 150(1):57-67. PubMed ID: 26892603
[TBL] [Abstract][Full Text] [Related]
44. Impact of Pulmonary Hypertension on Outcome in Patients with Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction.
Magne J; Mohty D; Piccardo A; Boulogne C; Deltreuil M; Petitalot V; Echahidi N; Darodes N; Virot P; Damy T; Aboyans V
Clin Res Cardiol; 2017 Jul; 106(7):542-550. PubMed ID: 28194496
[TBL] [Abstract][Full Text] [Related]
45. [Investigation of pulmonary hypertension].
Natali D; Simonneau G; Humbert M; Montani D
Rev Pneumol Clin; 2008 Jun; 64(3):151-61. PubMed ID: 18656791
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States.
Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
Curr Med Res Opin; 2011 Sep; 27(9):1763-8. PubMed ID: 21793646
[TBL] [Abstract][Full Text] [Related]
47. Echocardiographic screening for pulmonary hypertension in stable COPD out-patients and NT-proBNP as a rule-out test.
Andersen CU; Mellemkjaer S; Nielsen-Kudsk JE; Sønderskov LD; Laursen BE; Simonsen U; Hilberg O
COPD; 2012 Aug; 9(5):505-12. PubMed ID: 22708731
[TBL] [Abstract][Full Text] [Related]
48. [Pulmonary hypertension: definition, diagnostic and new classification].
Seferian A; Simonneau G
Presse Med; 2014 Sep; 43(9):935-44. PubMed ID: 25127985
[TBL] [Abstract][Full Text] [Related]
49. Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy.
Covella M; Rowin EJ; Hill NS; Preston IR; Milan A; Opotowsky AR; Maron BJ; Maron MS; Maron BA
Circ Heart Fail; 2017 Apr; 10(4):e003689. PubMed ID: 28396501
[TBL] [Abstract][Full Text] [Related]
50. Pulmonary artery ablation to treat pulmonary arterial hypertension: a case report.
Kiuchi MG; Andrea BR; da Silva GR; Coelho SB; Paz LM; Chen S; Souto GL
J Med Case Rep; 2015 Dec; 9():284. PubMed ID: 26670309
[TBL] [Abstract][Full Text] [Related]
51. Rheumatic valvulopathies occurence, pattern and follow-up in rural area: the experience of the Shisong Hospital, Cameroon.
Tantchou Tchoumi JC; Butera G
Bull Soc Pathol Exot; 2009 Aug; 102(3):155-8. PubMed ID: 19739409
[TBL] [Abstract][Full Text] [Related]
52. Healthcare burden of pulmonary hypertension owing to lung disease and/or hypoxia.
Heresi GA; Platt DM; Wang W; Divers CH; Joish VN; Teal SA; Yu JS
BMC Pulm Med; 2017 Apr; 17(1):58. PubMed ID: 28399914
[TBL] [Abstract][Full Text] [Related]
53. Secondary Pulmonary Hypertension Among Patients Qualified for Lung Transplantation: Single-Center Study.
Stącel T; Urlik M; Nęcki M; Antończyk R; Latos M; Wajda-Pokrontka M; Tatoj Z; Zawadzki F; Przybyłowski P; Zembala M; Ochman M
Transplant Proc; 2020 Sep; 52(7):2101-2109. PubMed ID: 32336653
[TBL] [Abstract][Full Text] [Related]
54. The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups.
Gall H; Felix JF; Schneck FK; Milger K; Sommer N; Voswinckel R; Franco OH; Hofman A; Schermuly RT; Weissmann N; Grimminger F; Seeger W; Ghofrani HA
J Heart Lung Transplant; 2017 Sep; 36(9):957-967. PubMed ID: 28302503
[TBL] [Abstract][Full Text] [Related]
55. The causes, treatment, and outcome of pulmonary hypertension in Africa: Insights from the Pan African Pulmonary Hypertension Cohort (PAPUCO) Registry.
Thienemann F; Dzudie A; Mocumbi AO; Blauwet L; Sani MU; Karaye KM; Ogah OS; Mbanze I; Mbakwem A; Udo P; Tibazarwa K; Damasceno A; Keates AK; Stewart S; Sliwa K
Int J Cardiol; 2016 Oct; 221():205-11. PubMed ID: 27404676
[TBL] [Abstract][Full Text] [Related]
56. An echocardiography audit to determine and characterise rheumatic heart disease lesions since 2012.
Munyandu NT
Cent Afr J Med; 2015; 61(1-4):17-20. PubMed ID: 29144093
[TBL] [Abstract][Full Text] [Related]
57. [Course of pulmonary hypertension in patients operated for rheumatic mitral heart disease].
Privalova EV; Cherepenin LP; Ershov VI; Baloian GM; Buravikhina TA; Ermakov AI; Ivanov AS
Ter Arkh; 2000; 72(4):58-62. PubMed ID: 10833802
[TBL] [Abstract][Full Text] [Related]
58. "From right to left": The role of right heart catheterization in the diagnosis and management of left heart diseases.
Kałużna-Oleksy M; Araszkiewicz A; Migaj J; Lesiak M; Straburzyńska-Migaj E
Adv Clin Exp Med; 2017; 26(1):135-141. PubMed ID: 28397445
[TBL] [Abstract][Full Text] [Related]
59. Assessment for Pulmonary Artery Hypertension Using Clinical and Echocardiographic Criteria in Patients With Systemic Sclerosis.
Methia N; Latreche S; Ait Mokhtar O; Monsuez JJ; Benkhedda S
Am J Med Sci; 2016 Oct; 352(4):343-347. PubMed ID: 27776714
[TBL] [Abstract][Full Text] [Related]
60. Current trends in the management of pulmonary hypertension associated with respiratory disease in institutions approved by the Japanese Respiratory Society.
Tanabe N; Taniguchi H; Tsujino I; Sakamaki F; Emoto N; Kimura H; Miyaji K; Takamura K; Hayashi S; Hanaoka M; Tatsumi K;
Respir Investig; 2014 May; 52(3):167-72. PubMed ID: 24853016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
